ShockWave Medical, Inc. Financials

Market Capitalization $7.25 Billion as of Jan. 1, 2024

Valuations Metrics as of May. 5, 2024

Trailing PE	85.54
Forward PE	53.43
Price to Sales TTM	$16.96
Price to Book MRQ	$18.27
Enterprise to Revenue	16.61
Enterprise to EBITDA	68.77

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	20.17%
Operating Margin	21.96%
Return on Assets TTM	9.38%
Return on Equity TTM	24.96%

Income Statement

Revenue TTM	$730,230,016
Revenue per Share TTM	$19.89
Quarterly Revenue Growth	40.90%
Gross Profit TTM	$634,842,000
EBITDA	$191,544,000
Net Income to Common TTM	$147,278,000
Diluted EPS TTM	$3.86
Quarterly Earnings Growth YoY	-68.60%

Balance Sheet

Total Cash MRQ	$990,553,984
Total Cash per Share MRQ	$26.49
Total Debt MRQ	$
Total Debt to Equity MRQ	115.24
Current Ratio MRQ	11.76
Book Value per Share MRQ	$18.08

Cash Flow

Operating Cash Flow TTM	$196,052,992
Levered Free Cash Flow TTM	$112,466,000

SWAV Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	37,507,700
Float Shares	36,854,188
Avg 10 Volume	873,120
Avg 30 Volume	None
Shares Short	1,467,970
Short Ratio	0.73
Short % of Shares	5.09%
% Held by Insiders	1.27%
% Held by Institutions	96.85%

Stock Price Summary

Beta	0.88
Fifty Two Week Low	$157.00
Fifty Two Week High	$331.58
Fifty Two Week Change	16.78%
Day 50 MA	$296.31
Day 200 MA	$232.46

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date